Skip to content

Clinical trials

Active, not recruiting Phase 3 Hematologic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 3 Status: Active, not recruiting Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20192
20215
20225
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.4
Agios Pharmaceuticals, Inc.2
Pfizer2
Vertex Pharmaceuticals Incorporated2
BioMarin Pharmaceutical1
Forma Therapeutics, Inc.1
Novartis Pharmaceuticals1
Swedish Orphan Biovitrum1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases14
Anemia4
Lymphoma, B-Cell4
Lymphoma, Non-Hodgkin4
Anemia, Sickle Cell3
Genetic Diseases, Inborn3
Hemoglobinopathies3
Leukemia, Lymphocytic, Chronic, B-Cell3
Hemophilia A2
Hemorrhagic Disorders2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.